Company / Working Capital
Oric Pharmaceuticals, Inc. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$268.0M
FY2025
5-year range
$192.1M / $268.0M
FY2021-FY2025
Trend
+12.9%
vs FY2024
Sector context
#152 of 213
Health Care
What the data says
At $268M, Oric Pharmaceuticals, Inc.'s working capital ranks #152 of 213 in the Health Care sector. Improved from $192M to $268M over the past 2 years.
Based on SEC 10-K filings.
$268M in FY2025 with a 5-year CAGR of -1.4%.
Improved from $192M to $268M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +11.2%
- 5-Year CAGR
- -1.4%
- 10-Year CAGR
- -
Sector benchmark
#152 of 213 in Health CareTop 71% of 213This company $268.0M Sector average $934.6M
▼
-71.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -1.4%, indicating a declining trend.
- In FY2025, working capital increased 12.9% year-over-year.
- Ranks #152 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $268.0M | +12.9% |
| FY2024 | $237.4M | +23.6% |
| FY2023 | $192.1M | -1.5% |
| FY2022 | $195.1M | -13.4% |
| FY2021 | $225.4M | -21.7% |
| FY2020 | $287.7M | +239.9% |
| FY2019 | $84.6M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026